Foamix Pharma Ord
(FOMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,686 | 59,925 | 55,522 | 43,399 | 52,165 |
| Marketable Securities | 16,680 | 15,621 | 14,373 | 39,398 | 46,937 |
| Receivables | 1,692 | 979 | 1,819 | 2,377 | 2,065 |
| Inventories | 1,356 | N/A | N/A | N/A | N/A |
| TOTAL | $76,414 | $76,525 | $71,714 | $85,174 | $101,167 |
| Non-Current Assets | |||||
| PPE Net | 2,885 | 2,809 | 2,497 | 2,297 | 2,235 |
| Investments And Advances | 0 | 143 | 139 | 137 | 283 |
| Other Non-Current Assets | 1,860 | 2,106 | 1,876 | 1,951 | 46 |
| TOTAL | $4,745 | $5,058 | $4,512 | $4,385 | $2,564 |
| Total Assets | $81,159 | $81,583 | $76,226 | $89,559 | $103,731 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 19,352 | 7,357 | 9,434 | 5,657 | 6,327 |
| Accrued Expenses | 3,381 | N/A | N/A | N/A | N/A |
| Other current liabilities | 5,501 | 4,877 | 3,664 | 2,859 | 4,141 |
| TOTAL | $29,326 | $13,370 | $14,097 | $9,430 | $10,468 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,725 | 12,939 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,533 | 1,745 | 1,747 | 2,134 | 1,081 |
| TOTAL | $34,258 | $14,684 | $1,747 | $2,134 | $1,081 |
| Total Liabilities | $63,584 | $28,054 | $15,844 | $11,564 | $11,549 |
| Shareholders' Equity | |||||
| Common Shares | 2,659 | 2,638 | 2,336 | 2,334 | 2,331 |
| Retained earnings | -310,587 | -272,767 | -249,606 | -230,613 | -215,409 |
| Other shareholders' equity | 5 | 1 | -1 | 8 | -43 |
| TOTAL | $17,575 | $53,529 | $60,382 | $77,995 | $92,182 |
| Total Liabilities And Equity | $81,159 | $81,583 | $76,226 | $89,559 | $103,731 |